(Q34331335)

1 August 2017

1 reference

title

Human alpha-1-glycoprotein and its interactions with drugs (English)

1 reference

1 August 2017

Israili ZH

1

1 reference

1 August 2017

Dayton PG

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

1 August 2017

published in

Drug Metabolism Reviews

1 reference

1 August 2017

volume

33

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

161-235

1 reference

Influence of binding on drug metabolism and distribution

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effects of plasma protein binding of drugs on duration and intensity of pharmacological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma and Tissue Binding Considerations in Drug Disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Disease-induced changes in the plasma binding of basic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The binding of chemically different psychotropic drugs to alpha 1-acid glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Quantitative structure-retention relationships in the examination of the topography of the binding site of antihistamine drugs on alpha 1-acid glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum alpha 1 acid glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

SC-52151, a novel inhibitor of the human immunodeficiency virus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Molecular cloning and nucleotide sequence of human alpha 1 acid glycoprotein cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Localization of human alpha 1 acid glycoprotein genes to 9q31----34.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Immunohistochemical localization of ?1-acid-glycoprotein in human liver parenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Endocytosis of alpha 1-acid glycoprotein variants by human monocytic lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Regulation of the acute phase response by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The acute phase protein response in patients receiving subcutaneous IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Thermal stability and ligand-binding properties of human plasma alpha 1-acid glycoprotein (orosomucoid) as determined with fluorescent probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Heat treatment of human serum to inactivate HIV does not alter protein binding of selected drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Differences in plasma binding of drugs between Caucasians and Chinese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effect of polymerized orosomucoid on some strains of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha-1-acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effects of alpha 1-acid glycoprotein in different rodent models of shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effect of polyions on the infectivity of SA-11 rotavirus in LCC-MK2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha 1-acid glycoprotein-induced tumor necrosis factor-α secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Recognition and invasion of human erythrocytes by malarial parasites: contribution of sialoglycoproteins to attachment and host specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Variations of the concentrations of certain glycoproteins in maternal serum, fetal serum and amniotic fluid during pregnancy (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Reproducibility and validity of maternal recall of pregnancy-related events

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Inhibitory effect of an antibody against alpha 1-acid glycoprotein (alpha 1-AGP) on autologous mixed lymphocyte reaction and anti-T3 T-lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Does alpha 1-acid glycoprotein act as a non-functional receptor for alpha 1-adrenergic antagonists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Incomplete or absent acute phase response in some postoperative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

THE ALPHA-1-ACID GLYCOPROTEIN VARIANTS OF NORMAL CAUCASIAN AND JAPANESE INDIVIDUALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The constancy of the alpha-1-acid glycoprotein variants of normal adults under conditions of severe stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Inheritance of human α1-acid glycoprotein (orosomucoid) variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Changes in serum alpha1 antitrypsin, alpha1 acid glycoprotein and beta2 glycoprotein i in patients with malignant hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha 1-acid glycoprotein concentration and molecular heterogeneity: relationship to oxprenolol binding in serum from healthy volunteers and patients with lung carcinoma or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Expression of the genetic variants of human alpha-1-acid glycoprotein in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Still's disease in children and adults: a distinct pattern of acute-phase proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Diurnal variation of alpha 1-acid glycoprotein concentration in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

A comparison of drug protein binding and alpha 1-acid glycoprotein concentration in Chinese and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Interethnic differences in drug protein binding and alpha 1 acid glycoprotein concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Differences between blacks and whites in plasma protein binding of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effects of age on the serum concentration of alpha 1-acid glycoprotein and the binding of lidocaine in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Relationship between the transplacental gradients of bupivacaine and alpha 1‐acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of drugs in pregnancy and in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The binding of basic drugs to alpha-acid glycoprotein in cord serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Stereoselective binding of propranolol in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Influence of menstrual cycle phase on serum concentrations of alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Bupivacaine protein binding in the term parturient: effects of lactic acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of bupivacaine in pregnant women at term.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Disopyramide pharmacokinetics and metabolism: effect of inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effects of cardiac surgery with cardiopulmonary bypass on lidocaine disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Serum glycoproteins and severity of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Serum α-1-acid glycoprotein as an index of dissemination in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens*

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Cimetidine does not increase alpha 1-acid glycoprotein serum concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Glucocorticoid-mediated induction of alpha 1-acid glycoprotein: evidence for hormone-regulated RNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effects of anabolic steroids on haptoglobin, orosomucoid, plasminogen, fibrinogen, transferrin, ceruloplasmin, alpha-1-antitrypsin, beta-glucuronidase and total serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Increase of alpha 1-acid glycoprotein after treatment with amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Enzyme induction with rifampicin; lipoproteins and drug binding to alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Comparative study of interaction mode of diazepines with human serum albumin and alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Quantitative relationships between the structure of beta-adrenolytic and antihistamine drugs and their retention on an alpha 1-acid glycoprotein HPLC column

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Clinical Consequences of the Lipophilicity and Plasma Protein Binding of Antiarrhythmic Drugs and Active Metabolites in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Evaluation of association constants between drug enantiomers and human alpha 1-acid glycoprotein by applying a partial-filling technique in affinity capillary electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Drug binding to alpha 1-acid glycoprotein studied by circular dichroism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Electron spin resonance study of human α1-acid glycoprotein interaction with a spin labelled steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The binding of ketamine to plasma proteins: emphasis on human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Steroid-protein interactions. XXI. Metal ion inhibition of association between progesterone and alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Differences in the serum protein binding of prazosin in man and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Differences in the binding of quinine and quinidine to plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The binding of the antimalarial arteether to human plasma proteins in-vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding of pyrimethamine to human plasma proteins and erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protein binding of chloroquine enantiomers and desethylchloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Enantioselective gallopamil protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Hematologic disposition of hydroxychloroquine enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The stereoselectivity of the 'single drug binding site' of human alpha 1-acid glycoprotein (orosomucoid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Stereoselective protein binding of verapamil enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Displacement of lidocaine from human plasma proteins by disopyramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Influence of bupivacaine on mepivacaine protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Influence of Crohn's disease on the pharmacokinetics and pharmacodynamics of alfentanil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Consequences of inflammatory processes on lignocaine protein binding during anaesthesia in fibreoptic bronchoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

In vitro protein binding of propafenone and 5-hydroxypropafenone in serum, in solutions of isolated serum proteins, and to red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding of 8-methoxypsoralen to human serum proteins and red blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Therapeutic drug monitoring of antiarrhythmic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

A comparison of the binding of drugs to adult and cord plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Decrease in penbutolol central response as a cause of changes in its serum protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of phencyclidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Variability in the plasma protein binding of velnacrine (1-hydroxy tacrine hydrochloride). A potential agent for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Lidocaine plasma protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha 1-acid glycoprotein and the binding of lidocaine in children with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Positive and negative acute phase proteins in affective subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Disposition of alfentanil in burns patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Factors affecting ceftriaxone plasma protein binding during open heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Clinical pharmacokinetics in organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Clinical pharmacokinetics and endocrine disorders. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The role of calcium ions in airway secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma binding variations of amitriptyline and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Interactions of aldosterone antagonist diuretics with human serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding of psychotropic drugs to isolated alpha-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Reversal of signs of induced cotton effects of dicumarol-alpha 1-acid glycoprotein systems by phenothiazine neuroleptics through ternary complexation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Cocaine and Cocaethylene Binding in Human Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protein binding of cocaine in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protein-protein interactions: analysis of the interaction of concanavalin A with serum glycoproteins by sedimentation equilibrium using an air-driven ultracentrifuge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Inter- and intrasubject variation in diazepam free fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding of diltiazem to albumin, alpha 1-acid glycoprotein and to serum in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of etidocaine during pregnancy and labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The plasma protein binding of metoclopramide in health and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Clinical pharmacokinetics of mibefradil

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding of norgestrel to human plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding in vitro of pipequaline (45319 RP) onto plasma proteins and blood cells in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Protein binding of propisomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Plasma protein binding of ritodrine at parturition and in nonpregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

The protein binding of timegadine determined by equilibrium dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Binding of toremifene to human serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Verapamil plasma binding: relationship to alpha 1-acid glycoprotein and drug efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Intravascular distribution of zidovudine: role of plasma proteins and whole blood components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Variations in relative concentrations of variants of human α1-acid glycoprotein after acute-phase conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Alpha-1-acid glycoprotein in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Human genetic variation in the Sierra de Gredos mountain (Central Spain): study of several polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Modulation of dipyridamole action by α1acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Biosensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

Determination of the Serum Protein Binding of Oxycodone and Morphine Using Ultrafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104402

21 January 2018

Identifiers

DOI

10.1081/DMR-100104402

1 reference

release_mvlvm2xodveivlkvinp4k5ckcy

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mvlvm2xodveivlkvinp4k5ckcy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference